Neutralizing antibody response to SARS‐CoV‐2 bivalent mRNA vaccine in SIV‐infected rhesus macaques: Enhanced immunity to XBB subvariants by two‐dose vaccination

Documenti analoghi

• Neutralizing antibody response after immunization with a COVID‐19 bivalent vaccine: Insights to the future
  di: Milena Silva Souza, et al.
  Pubblicazione: (2024)
• Blended BA.5 infection within 8 days after a boosted bivalent mRNA vaccination strengthens and lengthens the host immunity
  di: Mingzhu Huang, et al.
  Pubblicazione: (2024)
• A prospective humoral immune monitoring study of kidney transplant recipients receiving three doses of SARS‐CoV‐2 mRNA vaccine
  di: Cinzia Borgogna, et al.
  Pubblicazione: (2024)
• Poor durability of the neutralizing response against XBB sublineages after a bivalent mRNA COVID‐19 booster dose in persons with HIV
  di: Giulia Matusali, et al.
  Pubblicazione: (2024)
• Comparative single‐cell RNA sequencing analysis of immune response to inactivated vaccine and natural SARS‐CoV‐2 infection
  di: Shuai He, et al.
  Pubblicazione: (2024)